Gtcr Investment Xi Llc Sells 12,735,301 Shares of Sotera Health (NASDAQ:SHC) Stock

Sotera Health Company (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Gtcr Investment Xi Llc also recently made the following trade(s):

• On Friday, March 6th, Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00.

Sotera Health Stock Performance

SHC traded down $0.22 on Friday, reaching $15.27. The stock had a trading volume of 6,857,875 shares, compared to its average volume of 2,909,578. Sotera Health Company has a 12-month low of $10.80 and a 12-month high of $19.85. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. The business’s 50-day moving average price is $14.89 and its two-hundred day moving average price is $16.44. The company has a market cap of $4.35 billion, a P/E ratio of 37.24 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter in the previous year, the company earned $0.14 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Sell-side analysts forecast that Sotera Health Company will post 0.86 earnings per share for the current year.

Analyst Ratings Changes

SHC has been the subject of a number of recent analyst reports. Barclays cut their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Citigroup lifted their target price on shares of Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Piper Sandler reiterated an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Finally, Zacks Research lowered shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $20.33.

Institutional Trading of Sotera Health

Institutional investors have recently modified their holdings of the stock. IFP Advisors Inc grew its position in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new stake in shares of Sotera Health in the fourth quarter valued at about $27,000. Root Financial Partners LLC grew its position in shares of Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after purchasing an additional 1,455 shares during the period. True Wealth Design LLC grew its position in shares of Sotera Health by 389.3% in the fourth quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after purchasing an additional 1,456 shares during the period. Finally, EverSource Wealth Advisors LLC grew its position in shares of Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after purchasing an additional 2,935 shares during the period. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.